Identifying hepatitis C virus genotype 2/3 patients who can receive a 16‐week abbreviated course of peginterferon alfa‐2a (40KD) plus ribavirin

The objective of this analysis was to compare sustained virological response (SVR) and relapse rates in patients with a rapid virological response (RVR, HCV RNA

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Hepatology (Baltimore, Md.) Md.), 2010-06, Vol.51 (6), p.1897-1903
Hauptverfasser:	Diago, Moises, Shiffman, Mitchell L., Bronowicki, Jean‐Pierre, Zeuzem, Stefan, Rodriguez‐Torres, Maribel, Pappas, Stephen C., Tietz, Andreas, Nelson, David R.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antibiotics. Antiinfectious agents. Antiparasitic agents Antiviral agents Antiviral Agents - administration & dosage Biological and medical sciences Female Gastroenterology. Liver. Pancreas. Abdomen Genotype Hepacivirus - genetics Hepatitis C Hepatitis C virus Hepatitis C, Chronic - drug therapy Hepatology Humans Immunomodulators Interferon-alpha - administration & dosage Liver. Biliary tract. Portal circulation. Exocrine pancreas Logistic Models Male Medical sciences Middle Aged Pharmacology. Drug treatments Polyethylene Glycols - administration & dosage Recombinant Proteins Ribavirin - administration & dosage RNA, Viral - blood
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The objective of this analysis was to compare sustained virological response (SVR) and relapse rates in patients with a rapid virological response (RVR, HCV RNA
ISSN:	0270-9139 1527-3350
DOI:	10.1002/hep.23531